The interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori-infected Koreans

Cytokine

Volumn 51, Issue 2, 2010, Pages 158-165

  Song, Ji Hyun ^a   Kim, Sang Gyun ^b   Jung, Sung Ae ^c   Lee, Mi Kyoung ^b   Jung, Hyun Chae ^b   Song, In Sung ^b  

^a Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

Author keywords

Angiogenesis; Gastric cancer; Helicobacter pylori; Interleukin 8; Polymorphism

Indexed keywords

ANGIOPOIETIN 1; GELATINASE B; INTERLEUKIN 8; VASCULOTROPIN; ANGPT1 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; ANGIOGENESIS; ARTICLE; ATROPHIC GASTRITIS; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; KOREA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CARCINOGENESIS; ADENOCARCINOMA; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; METAPLASIA; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; STOMACH MUCOSA; STOMACH NEOPLASMS;

ADENOCARCINOMA; ADULT; AGED; ANGIOPOIETIN-1; ASIAN CONTINENTAL ANCESTRY GROUP; DISEASE PROGRESSION; FEMALE; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; KOREA; MALE; MATRIX METALLOPROTEINASE 9; METAPLASIA; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

HELICOBACTER PYLORI;

EID: 77954084304     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.05.001     Document Type: Article

References (46)

1. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992, 52:6735-6740.
2. Ding S.Z., Minohara Y., Fan X.J., Wang J., Reyes V.E., Patel J., et al. Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect Immun 2007, 75:4030-4039.
3. Baek H.Y., Lim J.W., Kim H., Kim J.M., Kim J.S., Jung H.C., et al. Oxidative-stress-related proteome changes in Helicobacter pylori-infected human gastric mucosa. Biochem J 2004, 379:291-299.
4. Bagchi D., Bhattacharya G., Stohs S.J. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res 1996, 24:439-450.
5. Maeda S., Yoshida H., Mitsuno Y., Hirata Y., Ogura K., Shiratori Y., et al. Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Gut 2002, 50:771-778.
6. Gupta R.A., Polk D.B., Krishna U., Israel D.A., Yan F., DuBois R.N., et al. Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells. J Biol Chem 2001, 276:31059-31066.
7. Kundu P., Mukhopadhyay A.K., Patra R., Banerjee A., Berg D.E., Swarnakar S. Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J Biol Chem 2006, 281:34651-34662.
8. Wu M.S., Lin J.T., Hsu P.N., Lin C.Y., Hsieh Y.T., Chiu Y.H., et al. Preferential induction of transforming growth factor-beta production in gastric epithelial cells and monocytes by Helicobacter pylori soluble proteins. J Infect Dis 2007, 196:1386-1393.
9. Crawford H.C., Krishna U.S., Israel D.A., Matrisian L.M., Washington M.K., Peek R.M. Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology 2003, 125:1125-1136.
10. Strowski M.Z., Cramer T., Schafer G., Juttner S., Walduck A., Schipani E., et al. Helicobacter pylori stimulates host vascular endothelial growth factor-A (VEGF-A) gene expression via MEK/ERK-dependent activation of Sp1 and Sp3. FASEB J 2004, 18:218-220.
11. Kitadai Y., Sasaki A., Ito M., Tanaka S., Oue N., Yasui W., et al. Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochem Biophys Res Commun 2003, 311:809-814.
12. Innocenti M., Thoreson A.C., Ferrero R.L., Stromberg E., Bolin I., Eriksson L., et al. Helicobacter pylori-induced activation of human endothelial cells. Infect Immun 2002, 70:4581-4590.
13. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 1990, 82:4-6.
14. Fox S.H., Whalen G.F., Sanders M.M., Burleson J.A., Jennings K., Kurtzman S., et al. Angiogenesis in normal tissue adjacent to colon cancer. J Surg Oncol 1998, 69:230-234.
15. Pousa I.D., Gisbert J.P. Gastric angiogenesis and Helicobacter pylori infection. Rev Esp Enferm Dig 2006, 98:527-541.
16. Sasaki A., Kitadai Y., Ito M., Sumii M., Tanaka S., Yoshihara M., et al. Helicobacter pylori infection influences tumor growth of human gastric carcinomas. Scand J Gastroenterol 2003, 38:153-158.
17. Eck M., Schmausser B., Scheller K., Toksoy A., Kraus M., Menzel T., et al. CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis. Clin Exp Immunol 2000, 122:192-199.
18. Kim J.S., Jung H.C., Kim J.M., Song I.S., Kim C.Y. Interleukin-8 expression by human neutrophils activated by Helicobacter pylori soluble proteins. Scand J Gastroenterol 1998, 33:1249-1255.
19. Kim J.S., Jung H.C., Kim J.M., Song I.S., Kim C.Y. Helicobacter pylori water-soluble surface proteins activate human neutrophils and up-regulate expression of CXC chemokines. Dig Dis Sci 2000, 45:83-92.
20. Mai U.E., Perez-Perez G.I., Wahl L.M., Wahl S.M., Blaser M.J., Smith P.D. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest 1991, 87:894-900.
21. Lindholm C., Quiding-Jarbrink M., Lonroth H., Hamlet A., Svennerholm A.M. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998, 66:5964-5971.
22. Ernst P.B., Crowe S.E., Reyes V.E. How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterology 1997, 113:S35-S42.
23. Kuipers E.J. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1997, 11(Suppl. 1):71-88.
24. Dixon M.F., Genta R.M., Yardley J.H., Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996, 20:1161-1181.
25. Arinir U., Klein W., Rohde G., Stemmler S., Epplen J.T., Schultze-Werninghaus G. Polymorphisms in the interleukin-8 gene in patients with chronic obstructive pulmonary disease. Electrophoresis 2005, 26:2888-2891.
26. Peterson G.L. A simplification of the protein assay method of Lowry et al. Which is more generally applicable. Anal Biochem 1977, 83:346-356.
27. Gologan A., Graham D.Y., Sepulveda A.R. Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med 2005, 25:197-222.
28. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402.
29. Xuan J., Deguchi R., Yanagi H., Ozawa H., Urano T., Ogawa Y., et al. Relationship between gastric mucosal IL-8 levels and histological gastritis in patients with Helicobacter pylori infection. Tokai J Exp Clin Med 2005, 30:83-88.
30. Ye B.D., Kim S.G., Park J.H., Kim J.S., Jung H.C., Song I.S. The interleukin-8-251 A allele is associated with increased risk of noncardia gastric adenocarcinoma in Helicobacter pylori-infected Koreans. J Clin Gastroenterol 2009, 43:233-239.
31. Ohyauchi M., Imatani A., Yonechi M., Asano N., Miura A., Iijima K., et al. The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005, 54:330-335.
32. Taguchi A., Ohmiya N., Shirai K., Mabuchi N., Itoh A., Hirooka Y., et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 2005, 14:2487-2493.
33. Lu W., Pan K., Zhang L., Lin D., Miao X., You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis 2005, 26:631-636.
34. Lee W.P., Tai D.I., Lan K.H., Li A.F., Hsu H.C., Lin E.J., et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 2005, 11:6431-6441.
35. Canedo P., Castanheira-Vale A.J., Lunet N., Pereira F., Figueiredo C., Gioia-Patricola L., et al. The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. Eur J Cancer Prev 2008, 17:28-32.
36. Savage S.A., Hou L., Lissowska J., Chow W.H., Zatonski W., Chanock S.J., et al. Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev 2006, 15:589-591.
37. Kitadai Y., Haruma K., Sumii K., Yamamoto S., Ue T., Yokozaki H., et al. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 1998, 152:93-100.
38. Kitadai Y., Takahashi Y., Haruma K., Naka K., Sumii K., Yokozaki H., et al. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer 1999, 81:647-653.
39. Tutton M.G., George M.L., Eccles S.A., Burton S., Swift R.I., Abulafi A.M. Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients. Int J Cancer 2003, 107:541-550.
40. Zheng H., Takahashi H., Murai Y., Cui Z., Nomoto K., Niwa H., et al. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 2006, 26:3579-3583.
41. Sun W.H., Sun Y.L., Fang R.N., Shao Y., Xu H.C., Xue Q.P., et al. Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis. Jpn J Clin Oncol 2005, 35:707-713.
42. Gao Z.L., Zhang C., Du G.Y., Lu Z.J. Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma. Hepatogastroenterology 2007, 54:1591-1595.
43. Tsigkos S., Koutsilieris M., Papapetropoulos A. Angiopoietins in angiogenesis and beyond. Expert Opin Investig Drugs 2003, 12:933-941.
44. Wang J., Wu K.C., Zhang D.X., Fan D.M. Antisense angiopoietin-1 inhibits tumorigenesis and angiogenesis of gastric cancer. World J Gastroenterol 2006, 12:2450-2454.
45. Yeo M., Kim D.K., Han S.U., Lee J.E., Kim Y.B., Cho Y.K., et al. Novel action of gastric proton pump inhibitor on suppression of Helicobacter pylori induced angiogenesis. Gut 2006, 55:26-33.
46. Varey A.H., Rennel E.S., Qiu Y., Bevan H.S., Perrin R.M., Raffy S., et al. VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer 2008, 98:1366-1379.